🔎 Trials Near Me

Beranda › Melanoma Uveal › New York

Uji klinis Melanoma Uveal di New York

7 studi untuk Melanoma Uveal mencari peserta di lokasi di New York.

Kota di New York

Teks studi resmi (Bahasa Inggris)

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

  • Memorial Sloan Kettering Westchester, Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05607095

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

  • Memorial Sloan Kettering Cancer Center, New York
  • Northwell Health, New York
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07804186

Adjuvant Tebentafusp in High Risk Ocular Melanoma

  • Northwell Health -Center for Advanced Medicine, Lake Success
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06246149

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

  • Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center - 1275 York Ave, New York
  • Northwell Health Cancer Institute, New York
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 2/3
Semua usia · Semua jenis kelamin · Diperbarui 2 Apr 2026 · NCT06581406

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

  • Northwell Health Center for Advanced Medicine, New Hyde Park
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Des 2025 · NCT06121180

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.